Table 2.
Subjective participant data collected from epidemiologic survey.
|
Study no. |
AIHa | PBCb |
No. of immuno-suppression prescriptions |
UDCAc |
| 1 | Yes | Yes | 2 | No |
| 2 | Yes | Yes | 0 | Yes |
| 3 | Yes | No | 0 | Yes |
| 4 | Yes | No | 2 | Yes |
| 5 | Yes | No | 2 | Yes |
| 6 | Yes | No | 2 | No |
| 7 | Yes | Yes | 2 | No |
| 8 | Yes | No | 1 | No |
| 9 | Yes | No | 1 | No |
| 10 | Yes | Yes | 1 | Yes |
| 11 | Yes | No | 2 | No |
| 12 | Yes | No | 0 | No |
| 13 | Yes | No | 0 | No |
| 14 | Yes | Yes | 0 | Yes |
| 15 | Yes | No | 1 | Yes |
| 16 | Yes | No | 0 | No |
| 17 | Yes | No | 1 | No |
| 18 | Yes | Yes | 1 | Yes |
| 19 | Yes | No | 1 | Yes |
| 20 | Yes | Yes | — | Yes |
| 21 | Yes | No | 0 | No |
| 22 | Yes | Yes | 1 | Yes |
| 23 | Yes | No | 2 | No |
| 24 | Yes | No | 2 | No |
| 25 | Yes | No | 2 | No |
| 26 | Yes | No | 2 | No |
| 27 | Yes | Yes | 2 | No |
| 28 | Yes | No | 1 | No |
| 29 | Yes | No | 1 | No |
aAIH: autoimmune hepatitis.
bPBC: primary biliary cholangitis.
cUDCA: ursodeoxycholic acid.